COMMUNIQUÉS West-GlobeNewswire

Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor
04/03/2025
TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. [...]
H.H.C. Group Highlights Flat-Fee Approach to Dialysis Claim Review, Unveils Cost-Saving Case Study for March Kidney Month
04/03/2025
ROCKVILLE, Md., March 04, 2025 (GLOBE NEWSWIRE) -- Recognizing March as National Kidney Month , H.H.C. Group (H.H.C.), the leader in reducing healthcare costs by providing high-quality cost containment using claim [...]
Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders
04/03/2025
Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted [...]
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
03/03/2025
MELBOURNE, Australia and INDIANAPOLIS, March 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company’s late-stage [...]
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
03/03/2025
SAN FRANCISCO, March 03, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce fourth quarter and full year 2024 financial results on Monday, March 17 after the markets close. FibroGen will also conduct a [...]
23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
03/03/2025
SUNNYVALE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME) today confirmed receipt of a non-binding proposal [...]
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
03/03/2025
Company to Host Conference Call on March 20 at 8:30 a.m. ET SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients [...]
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03/03/2025
MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life [...]
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
03/03/2025
PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® Gel (repository [...]
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
03/03/2025
TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor [...]
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
03/03/2025
Nyxoah to Participate in the Oppenheimer 35 th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – March 3, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
Nyxoah Participera à la 35ème Oppenheimer Annual Healthcare MedTech & Services Conference
03/03/2025
Nyxoah Participera à la 35 ème Oppenheimer Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgique – 3 mars 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » [...]
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
03/03/2025
Fourth Quarter 2024 Total Revenues of $194.7 million; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million, decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 [...]
Tenaya Therapeutics Announces Proposed Public Offering
03/03/2025
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Amwell makes inducement grant
03/03/2025
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) covering 220,844 shares [...]
Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025
03/03/2025
TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quarter and fiscal year 2024 [...]
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
03/03/2025
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug [...]
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
03/03/2025
Received FDA approval for Eversense ® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately 6,000 global [...]
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
03/03/2025
BALA CYNWYD, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]

Pages